Lidocaine Hcl Solution
Product Images NDC 51662-1553

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lidocaine Hcl (NDC 51662-1553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial P1 (51662 1553 2 Laryng O Jet Labeling)

Label for Lidocaine Hydrochloride Topical Solution USP, 4%, a sterile aqueous topical solution in single-dose 4 mL packaging. Contains 160 mg total, equivalent to 40 mg/mL strength. The label states it is for topical use only and not for injection. Manufactured by IMS Limited, California, USA.*

FDA Label Image

Pouch Labeling (51662 1553 2 Pouch Labeling)

Label of Lidocaine HCl Topical Solution USP 4% 160 mg/4 mL in a 4 mL Laryng-O-Jet kit, covered with detailed product information including NDC 51662-1553-2, lot number, expiration date, storage instructions, and manufacturer details by HF Acquisition Co., LLC, Mukilteo, WA.*

FDA Label Image

Case Labeling (51662 1553 3 Case Labeling)

LIDOCAINE HCl topical solution USP 4%, 160 mg/4 mL, 4 mL LARYNG-O-JET kit package label. Shows NDC 51662-1553-3, lot number 12345, expiration date 2025-01-01. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA. Label includes handling and storage instructions and states Rx only.*

FDA Label Image

Serialized Labeling (51662 1553 3 Serialized Labeling)

A rectangular white label featuring barcode data and text. It includes GS1 Application Identifiers such as (01) for the Global Trade Item Number, (17) for expiration date, (21) for serial number, and (10) for batch or lot number. The label states "See manufacturer's package insert" and notes distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275, with "RX ONLY" printed vertically on the right side.*

FDA Label Image

Vial P2 (51662 155302 Lyryng O Jet Labeling Part 2)

Label for Lidocaine Hydrochloride Topical Solution USP 4%, 160 mg/4 mL (40 mg/mL) sterile aqueous solution. The label includes warnings about not bending the cannula and instructions for use with a laryngoscope as part of the Laryng-O-Jet Sterile Pak kit. It is labeled for prescription use only, distributed by HF Acquisition Co LLC, DBA HealthFirst, with Product NDC 51662-1553.*

FDA Label Image

Description (Description)

Chemical structure of lidocaine hydrochloride (LIDOCAINE HCl). The diagram shows the molecular structure and includes the molecular formula C14H22N2O·HCl with a molecular weight of 270.80.*

FDA Label Image

D2 (Dosage And Administration 2)

An instructional line drawing showing a hand holding a tongue depressor to press down a tongue for an interior view of the mouth and throat. The diagram appears to demonstrate a procedure or examination related to oral or throat access, typical in medical or dental contexts.*

FDA Label Image

D1 (Dosage And Administration)

A labeled black-and-white line diagram illustrating the assembled LARYNG-O-JET system for lidocaine hydrochloride topical solution. The diagram identifies parts including the vial cap, vial injector cap, vial injector with injector finger tab, cannula, guide mark, and jet openings, with an inset showing the front view of the jet openings' direction.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.